BREAKING: Asian Stocks Down Over Waning COVID-19 Vaccine Optimism
Photo: Reuters
Investing.com – Asia Pacific stocks were mostly down on Friday morning, ending the week on a cautious note as investors digested valuations from a record rally in global stocks earlier in the week and a stubborn second wave of COVID-19 cases in the U.S. and Europe.
Japan’s Nikkei 225 inched down 0.07% by 10:49 PM ET (2:49 AM GMT).
South Korea’s KOSPI inched down 0.06% as the country reported 583 daily cases on Thursday, the first time the number has exceeded 500 since early March.
In Australia, the ASX 200 was down 0.63%.
China’s Ministry of Commerce said in a statement released earlier in the day that China will impose temporary anti-dumping measures on wine imported from Australia starting Nov 28.
Hong Kong’s Hang Seng Index edged down 0.15%.
China’s Shanghai Composite was up 0.41% while the Shenzhen Component was up 0.38%.
Data released earlier in the day showed that the Chinese Industrial Profit (CIP) rose 28.20% year-on-year in October, against September’s 10.10% growth.
Global shares continued a pullback from the rally earlier in the week, with AstraZeneca PLC likely to put its COVID-19 vaccine candidate AZD 1222 though an additional global trial in order to clear confusion surrounding the positive results from the current study announced earlier in the week, Chief Executive Officer Pascal Soriot said.
Original article:
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.